Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback